First Patient Dosed in UK Trial of Epitopea Ovarian Cancer Vaccine
Audio narration · Coming soon
The first patient has been administered an experimental ovarian cancer vaccine developed by Epitopea in a UK clinical trial. This trial aims to evaluate the vaccine's safety and initial indications of its effectiveness against ovarian cancer.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews